{"entity":{"type":"insider","cik":"0001780851","url":"/insider/0001780851","json_url":"/insider/0001780851.json","name":"ROBINS HARLAN S","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":164,"n_filings":44,"first":"2020-01-17","last":"2026-07-23","span_basis":"filed_date"},"name_variants":[{"name":"ROBINS HARLAN S","source":"filing","n_filings":44,"first_seen":"2020-01-17","last_seen":"2026-07-23"}],"transactions":[{"id":5935616,"accession":"0001780851-26-000017","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001780851-26-000017","line_url":"/filing/0001780851-26-000017","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":492400.0,"shares_display":"492,400","price_per_share":21.893600324939072,"price_display":"21.89","price_state":"stated","total_value":10780408.8,"total_display":"10,780,408.80","total_whole":"10,780,409","shares_owned_after":1025760.0,"shares_owned_after_display":"1,025,760","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-21","filed_date":"2026-07-23","scope":"insider","n_lines":2},{"id":5816221,"accession":"0001780851-26-000015","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001780851-26-000015","line_url":"/filing/0001780851-26-000015","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":386240.0,"shares_display":"386,240","price_per_share":22.010016544117647,"price_display":"22.01","price_state":"stated","total_value":8501148.79,"total_display":"8,501,148.79","total_whole":"8,501,149","shares_owned_after":1166547.0,"shares_owned_after_display":"1,166,547","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-02","filed_date":"2026-07-07","scope":"insider","n_lines":2},{"id":6004946,"accession":"0001780851-26-000013","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001780851-26-000013","line_url":"/filing/0001780851-26-000013#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6160.0,"shares_display":"6,160","price_per_share":18.01,"price_display":"18.01","price_state":"stated","total_value":110941.6,"total_display":"110,941.60","total_whole":"110,942","shares_owned_after":1405898.0,"shares_owned_after_display":"1,405,898","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-16","filed_date":"2026-06-17","scope":"insider"},{"id":6004942,"accession":"0001780851-26-000013","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001780851-26-000013","line_url":"/filing/0001780851-26-000013#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":17.37,"price_display":"17.37","price_state":"stated","total_value":1737000.0,"total_display":"1,737,000.00","total_whole":"1,737,000","shares_owned_after":1412058.0,"shares_owned_after_display":"1,412,058","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-15","filed_date":"2026-06-17","scope":"insider"},{"id":5876418,"accession":"0001780851-26-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001780851-26-000011","line_url":"/filing/0001780851-26-000011#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":14.85,"price_display":"14.85","price_state":"stated","total_value":148500.0,"total_display":"148,500.00","total_whole":"148,500","shares_owned_after":1512058.0,"shares_owned_after_display":"1,512,058","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-08","filed_date":"2026-04-10","scope":"insider"},{"id":5886576,"accession":"0001780851-26-000007","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001780851-26-000007","line_url":"/filing/0001780851-26-000007","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":470266.0,"shares_display":"470,266","price_per_share":13.17,"price_display":"13.17","price_state":"stated","total_value":6193403.22,"total_display":"6,193,403.22","total_whole":"6,193,403","shares_owned_after":1522058.0,"shares_owned_after_display":"1,522,058","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-11","filed_date":"2026-03-13","scope":"insider","n_lines":2},{"id":5923727,"accession":"0001780851-26-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001780851-26-000003","line_url":"/filing/0001780851-26-000003#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14233.0,"shares_display":"14,233","price_per_share":16.52,"price_display":"16.52","price_state":"stated","total_value":235129.16,"total_display":"235,129.16","total_whole":"235,129","shares_owned_after":1155291.0,"shares_owned_after_display":"1,155,291","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-03","filed_date":"2026-03-04","scope":"insider"},{"id":5923724,"accession":"0001780851-26-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001780851-26-000003","line_url":"/filing/0001780851-26-000003#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":15.72,"price_display":"15.72","price_state":"stated","total_value":157200.0,"total_display":"157,200.00","total_whole":"157,200","shares_owned_after":1169524.0,"shares_owned_after_display":"1,169,524","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider"},{"id":5829069,"accession":"0001780851-26-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001780851-26-000002","line_url":"/filing/0001780851-26-000002#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8120.0,"shares_display":"8,120","price_per_share":19.0,"price_display":"19.00","price_state":"stated","total_value":154280.0,"total_display":"154,280.00","total_whole":"154,280","shares_owned_after":1179524.0,"shares_owned_after_display":"1,179,524","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-03","filed_date":"2026-02-04","scope":"insider"},{"id":5829067,"accession":"0001780851-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001780851-26-000002","line_url":"/filing/0001780851-26-000002#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34668.0,"shares_display":"34,668","price_per_share":18.6,"price_display":"18.60","price_state":"stated","total_value":644824.8,"total_display":"644,824.80","total_whole":"644,825","shares_owned_after":1187644.0,"shares_owned_after_display":"1,187,644","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-02","filed_date":"2026-02-04","scope":"insider"},{"id":5816217,"accession":"0001780851-26-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001780851-26-000001","line_url":"/filing/0001780851-26-000001#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":16.44,"price_display":"16.44","price_state":"stated","total_value":164400.0,"total_display":"164,400.00","total_whole":"164,400","shares_owned_after":1222312.0,"shares_owned_after_display":"1,222,312","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-06","filed_date":"2026-01-08","scope":"insider"},{"id":4824586,"accession":"0001780851-25-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001780851-25-000003","line_url":"/filing/0001780851-25-000003#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":16.61,"price_display":"16.61","price_state":"stated","total_value":166100.0,"total_display":"166,100.00","total_whole":"166,100","shares_owned_after":1232312.0,"shares_owned_after_display":"1,232,312","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-04","filed_date":"2025-12-05","scope":"insider"},{"id":4824579,"accession":"0001780851-25-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001780851-25-000003","line_url":"/filing/0001780851-25-000003#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27212.0,"shares_display":"27,212","price_per_share":18.61,"price_display":"18.61","price_state":"stated","total_value":506415.32,"total_display":"506,415.32","total_whole":"506,415","shares_owned_after":1242312.0,"shares_owned_after_display":"1,242,312","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-03","filed_date":"2025-12-05","scope":"insider"},{"id":4213222,"accession":"0001780851-25-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001780851-25-000002","line_url":"/filing/0001780851-25-000002#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":14.82,"price_display":"14.82","price_state":"stated","total_value":148200.0,"total_display":"148,200.00","total_whole":"148,200","shares_owned_after":1269524.0,"shares_owned_after_display":"1,269,524","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-10","filed_date":"2025-11-12","scope":"insider"},{"id":4167305,"accession":"0001062993-25-008509","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-25-008509","line_url":"/filing/0001062993-25-008509#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":68412.0,"shares_display":"68,412","price_per_share":7.35,"price_display":"7.35","price_state":"stated","total_value":502828.2,"total_display":"502,828.20","total_whole":"502,828","shares_owned_after":1279524.0,"shares_owned_after_display":"1,279,524","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-05-01","filed_date":"2025-05-05","scope":"insider"},{"id":5077672,"accession":"0001062993-25-006335","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-25-006335","line_url":"/filing/0001062993-25-006335#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1698.0,"shares_display":"1,698","price_per_share":9.0,"price_display":"9.00","price_state":"stated","total_value":15282.0,"total_display":"15,282.00","total_whole":"15,282","shares_owned_after":1279524.0,"shares_owned_after_display":"1,279,524","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-24","filed_date":"2025-03-26","scope":"insider"},{"id":5077521,"accession":"0001062993-25-004810","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-25-004810","line_url":"/filing/0001062993-25-004810","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":96656.0,"shares_display":"96,656","price_per_share":6.985799226121503,"price_display":"6.99","price_state":"stated","total_value":675219.41,"total_display":"675,219.41","total_whole":"675,219","shares_owned_after":1279524.0,"shares_owned_after_display":"1,279,524","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-06","scope":"insider","n_lines":2},{"id":6481818,"accession":"0001209191-22-017394","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-017394","line_url":"/filing/0001209191-22-017394#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4517.0,"shares_display":"4,517","price_per_share":12.01,"price_display":"12.01","price_state":"stated","total_value":54249.17,"total_display":"54,249.17","total_whole":"54,249","shares_owned_after":311960.0,"shares_owned_after_display":"311,960","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-07","filed_date":"2022-03-08","scope":"insider"},{"id":4386821,"accession":"0001209191-21-065839","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-065839","line_url":"/filing/0001209191-21-065839#line-4","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":300.0,"shares_display":"300","price_per_share":31.36,"price_display":"31.36","price_state":"stated","total_value":9408.0,"total_display":"9,408.00","total_whole":"9,408","shares_owned_after":69360.0,"shares_owned_after_display":"69,360","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-18","filed_date":"2021-11-19","scope":"insider"},{"id":4386815,"accession":"0001209191-21-065839","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-065839","line_url":"/filing/0001209191-21-065839#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3700.0,"shares_display":"3,700","price_per_share":32.05,"price_display":"32.05","price_state":"stated","total_value":118585.0,"total_display":"118,585.00","total_whole":"118,585","shares_owned_after":69360.0,"shares_owned_after_display":"69,360","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-17","filed_date":"2021-11-19","scope":"insider"},{"id":4841170,"accession":"0001209191-21-061319","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-21-061319","line_url":"/filing/0001209191-21-061319#line-7","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3700.0,"shares_display":"3,700","price_per_share":33.73,"price_display":"33.73","price_state":"stated","total_value":124801.0,"total_display":"124,801.00","total_whole":"124,801","shares_owned_after":69360.0,"shares_owned_after_display":"69,360","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-21","filed_date":"2021-10-21","scope":"insider"},{"id":4841162,"accession":"0001209191-21-061319","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-061319","line_url":"/filing/0001209191-21-061319#line-5","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3700.0,"shares_display":"3,700","price_per_share":33.71,"price_display":"33.71","price_state":"stated","total_value":124727.0,"total_display":"124,727.00","total_whole":"124,727","shares_owned_after":69360.0,"shares_owned_after_display":"69,360","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-20","filed_date":"2021-10-21","scope":"insider"},{"id":4841150,"accession":"0001209191-21-061319","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-061319","line_url":"/filing/0001209191-21-061319","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3800.0,"shares_display":"3,800","price_per_share":33.692894736842106,"price_display":"33.69","price_state":"stated","total_value":128033.0,"total_display":"128,033.00","total_whole":"128,033","shares_owned_after":69360.0,"shares_owned_after_display":"69,360","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-19","filed_date":"2021-10-21","scope":"insider","n_lines":2},{"id":4143403,"accession":"0001209191-21-060115","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-21-060115","line_url":"/filing/0001209191-21-060115#line-7","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3895.0,"shares_display":"3,895","price_per_share":32.96,"price_display":"32.96","price_state":"stated","total_value":128379.2,"total_display":"128,379.20","total_whole":"128,379","shares_owned_after":69360.0,"shares_owned_after_display":"69,360","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-08","filed_date":"2021-10-08","scope":"insider"},{"id":4143395,"accession":"0001209191-21-060115","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-060115","line_url":"/filing/0001209191-21-060115","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3895.0,"shares_display":"3,895","price_per_share":33.61940949935815,"price_display":"33.62","price_state":"stated","total_value":130947.6,"total_display":"130,947.60","total_whole":"130,948","shares_owned_after":69360.0,"shares_owned_after_display":"69,360","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-07","filed_date":"2021-10-08","scope":"insider","n_lines":2},{"id":4143384,"accession":"0001209191-21-060115","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-060115","line_url":"/filing/0001209191-21-060115#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3895.0,"shares_display":"3,895","price_per_share":32.27,"price_display":"32.27","price_state":"stated","total_value":125691.65,"total_display":"125,691.65","total_whole":"125,692","shares_owned_after":69360.0,"shares_owned_after_display":"69,360","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-06","filed_date":"2021-10-08","scope":"insider"},{"id":4741034,"accession":"0001209191-21-056261","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-21-056261","line_url":"/filing/0001209191-21-056261","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3895.0,"shares_display":"3,895","price_per_share":36.68405648267009,"price_display":"36.68","price_state":"stated","total_value":142884.4,"total_display":"142,884.40","total_whole":"142,884","shares_owned_after":70260.0,"shares_owned_after_display":"70,260","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-15","filed_date":"2021-09-15","scope":"insider","n_lines":2},{"id":4741026,"accession":"0001209191-21-056261","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-21-056261","line_url":"/filing/0001209191-21-056261","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3895.0,"shares_display":"3,895","price_per_share":36.73569961489088,"price_display":"36.74","price_state":"stated","total_value":143085.55,"total_display":"143,085.55","total_whole":"143,086","shares_owned_after":70460.0,"shares_owned_after_display":"70,460","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-14","filed_date":"2021-09-15","scope":"insider","n_lines":2},{"id":4741015,"accession":"0001209191-21-056261","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-056261","line_url":"/filing/0001209191-21-056261","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3895.0,"shares_display":"3,895","price_per_share":37.50553273427471,"price_display":"37.51","price_state":"stated","total_value":146084.05,"total_display":"146,084.05","total_whole":"146,084","shares_owned_after":70260.0,"shares_owned_after_display":"70,260","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-13","filed_date":"2021-09-15","scope":"insider","n_lines":2},{"id":5402948,"accession":"0001209191-21-053766","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-21-053766","line_url":"/filing/0001209191-21-053766","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3895.0,"shares_display":"3,895","price_per_share":34.775086007702185,"price_display":"34.78","price_state":"stated","total_value":135448.96,"total_display":"135,448.96","total_whole":"135,449","shares_owned_after":69360.0,"shares_owned_after_display":"69,360","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-27","filed_date":"2021-08-27","scope":"insider","n_lines":2},{"id":5402940,"accession":"0001209191-21-053766","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-053766","line_url":"/filing/0001209191-21-053766#line-4","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3895.0,"shares_display":"3,895","price_per_share":33.89,"price_display":"33.89","price_state":"stated","total_value":132001.55,"total_display":"132,001.55","total_whole":"132,002","shares_owned_after":69360.0,"shares_owned_after_display":"69,360","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-26","filed_date":"2021-08-27","scope":"insider"},{"id":5402936,"accession":"0001209191-21-053766","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-053766","line_url":"/filing/0001209191-21-053766#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3895.0,"shares_display":"3,895","price_per_share":34.09,"price_display":"34.09","price_state":"stated","total_value":132780.55,"total_display":"132,780.55","total_whole":"132,781","shares_owned_after":69360.0,"shares_owned_after_display":"69,360","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-25","filed_date":"2021-08-27","scope":"insider"},{"id":4669679,"accession":"0001209191-21-047649","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001209191-21-047649","line_url":"/filing/0001209191-21-047649","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3895.0,"shares_display":"3,895","price_per_share":37.815263157894734,"price_display":"37.82","price_state":"stated","total_value":147290.45,"total_display":"147,290.45","total_whole":"147,290","shares_owned_after":69360.0,"shares_owned_after_display":"69,360","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-21","filed_date":"2021-07-21","scope":"insider","n_lines":2},{"id":4669664,"accession":"0001209191-21-047649","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-21-047649","line_url":"/filing/0001209191-21-047649","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3895.0,"shares_display":"3,895","price_per_share":37.48290115532734,"price_display":"37.48","price_state":"stated","total_value":145995.9,"total_display":"145,995.90","total_whole":"145,996","shares_owned_after":69360.0,"shares_owned_after_display":"69,360","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-20","filed_date":"2021-07-21","scope":"insider","n_lines":2},{"id":4669652,"accession":"0001209191-21-047649","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-047649","line_url":"/filing/0001209191-21-047649","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3895.0,"shares_display":"3,895","price_per_share":37.124097560975606,"price_display":"37.12","price_state":"stated","total_value":144598.36,"total_display":"144,598.36","total_whole":"144,598","shares_owned_after":69360.0,"shares_owned_after_display":"69,360","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-19","filed_date":"2021-07-21","scope":"insider","n_lines":2},{"id":5045442,"accession":"0001209191-21-040100","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-21-040100","line_url":"/filing/0001209191-21-040100#line-8","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3895.0,"shares_display":"3,895","price_per_share":38.41,"price_display":"38.41","price_state":"stated","total_value":149606.95,"total_display":"149,606.95","total_whole":"149,607","shares_owned_after":69360.0,"shares_owned_after_display":"69,360","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-11","filed_date":"2021-06-11","scope":"insider"},{"id":5045434,"accession":"0001209191-21-040100","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-21-040100","line_url":"/filing/0001209191-21-040100#line-6","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001780851","owner_name":"ROBINS HARLAN S","owner_display_name":"ROBINS HARLAN S","owner_url":"/insider/0001780851","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2795.0,"shares_display":"2,795","price_per_share":37.87,"price_display":"37.87","price_state":"stated","total_value":105846.65,"total_display":"105,846.65","total_whole":"105,847","shares_owned_after":69360.0,"shares_owned_after_display":"69,360","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-10","filed_date":"2021-06-11","scope":"insider"}],"collapsed":true,"next_cursor":"2021-06-10|5045434","ledger_fault":false,"count":{"value":164,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":164,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":164},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001478320","name":"Adaptive Biotechnologies Corp","url":"/issuer/0001478320","role":"Officer (Chief Scientific Officer)","n_filings":44,"first_seen":"2020-01-17","last_seen":"2026-07-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001780851","retrieved_at":"2026-08-27T01:24:12+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}